Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial

BACKGROUND AND AIMS: The efficacy of new therapies for ulcerative colitis [UC] is usually influenced by previous biologic use. These post hoc analyses of SELECTION, a placebo-controlled phase 2b/3 trial in patients with moderately to severely active UC, evaluated the efficacy of filgotinib, an oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Dotan, Iris, Feagan, Brian G, Taliadouros, Virginia, Oortwijn, Alessandra, Rudolph, Christine, de Haas, Angela, Santermans, Eva, Hsieh, Jeremy, Peyrin-Biroulet, Laurent, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441561/
https://www.ncbi.nlm.nih.gov/pubmed/36928705
http://dx.doi.org/10.1093/ecco-jcc/jjad039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441561/
https://www.ncbi.nlm.nih.gov/pubmed/36928705
http://dx.doi.org/10.1093/ecco-jcc/jjad039

Ejemplares similares